News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

RADNOR, PA — Idorsia Pharmaceuticals U.S. Inc. has announced the availability of TRYVIO™ (aprocitentan) in the United States ...

For centuries, bird's nest soup has been consumed in Asian countries for its purported health benefits. Now, it's helping to ...

SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...

Middle-aged adults with long-term fluctuations in blood pressure may face a higher risk for sudden cardiac death than their ...

High blood pressure, also called hypertension, is often referred to as a “silent killer” because it doesn’t always show ...

Commonly prescribed drugs used to treat high blood pressure have been shown to, over time, wreck the kidneys' ability to ...

– Taking high doses (more than 1000 mg) of calcium supplements during pregnancy may lead to slightly fewer babies being born before 37 weeks of pregnancy. There was possibly no difference in unwanted ...

The Company is also developing a next-generation, non-surgical transcatheter based replacement venous valve called enVVe, which could appeal to an even larger market in terms of both patients and ...

For many people, the immune system can clear those symptoms in about a week. But for others, flu can lead to severe illness, ...

Researchers at the UVA School of Medicine are researching how certain blood pressure medications can damage the kidneys.

Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and ...